Eyal Attar
2023
In 2023, Eyal Attar earned a total compensation of $1.4M as Chief Medical Officer at Vor Biopharma.
Compensation breakdown
| Non-Equity Incentive Plan | $180,286 |
|---|---|
| Option Awards | $437,090 |
| Salary | $474,000 |
| Stock Awards | $302,475 |
| Other | $6,269 |
| Total | $1,400,120 |
Attar received $474K in salary, accounting for 34% of the total pay in 2023.
Attar also received $180.3K in non-equity incentive plan, $437.1K in option awards, $302.5K in stock awards and $6.3K in other compensation.
Rankings
In 2023, Eyal Attar's compensation ranked 847th out of 3,006 executives tracked by ExecPay. In other words, Attar earned more than 71.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 847 out of 3,006 | 72nd |
Division Manufacturing | 495 out of 1,650 | 70th |
Major group Chemicals And Allied Products | 337 out of 918 | 63rd |
Industry group Drugs | 328 out of 881 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 103 out of 213 | 52nd |
Source: SEC filing on April 9, 2024.
Attar's colleagues
We found two more compensation records of executives who worked with Eyal Attar at Vor Biopharma in 2023.